Related Experiment Video

Updated: Jul 5, 2026

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
10:24

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins

Published on: September 28, 2012

Damaged DNA binding protein 2 plays a role in breast cancer cell growth

Zilal Kattan1, Sophie Marchal, Emilie Brunner

  • 1Laboratoire de Biologie Cellulaire du Développement, EA 3446 Université Henri Poincaré-Nancy Université, Vandoeuvre-lès-Nancy, France.

Plos One
|April 24, 2008
PubMed

Insights

Damaged DNA binding protein 2 (DDB2) acts as an oncogene in breast cancer, promoting cell growth and colony formation, particularly in estrogen receptor-positive tumors. DDB2 may serve as a predictive marker for breast cancer.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Damaged DNA binding protein 2 (DDB2) is involved in DNA repair, transcription, and cell cycle regulation.
  • Loss of DDB2 function is potentially linked to tumor susceptibility.
  • This study investigated the role of DDB2 in breast cancer cell growth, focusing on its interaction with the E2F1 marker.

Purpose of the Study:

  • To determine if DDB2 plays a role in breast cancer cell proliferation.
  • To explore DDB2's potential as a predictive marker in breast cancer.

Main Methods:

  • Gene expression analysis in breast cancer cell lines and patient tumor samples.
  • DDB2 knockdown using small interfering RNA (siRNA) in MCF-7 cells.
  • DDB2 gene introduction into MDA-MB231 cells.
  • Flow cytometry for cell cycle analysis and proliferation assessment (5-Bromodeoxyuridine incorporation).
  • Analysis of S phase marker expression (PCNA, cyclin E, DHFR).

Main Results:

  • DDB2 was overexpressed in estrogen receptor (ER)-positive breast cancer cells and tumor samples compared to ER-negative counterparts.
  • DDB2 knockdown inhibited growth and colony formation in MCF-7 cells.
  • DDB2 introduction stimulated growth and colony formation in MDA-MB231 cells.
  • DDB2 knockdown led to delayed G1/S transition and slowed S phase progression, with decreased expression of S phase markers.

Conclusions:

  • DDB2 functions as an oncogene in breast cancer, promoting cell growth.
  • DDB2 expression is associated with ER-positive breast cancer.
  • DDB2 is a potential predictive marker for breast cancer.

More Related Videos

Visualization of DNA Repair Proteins Interaction by Immunofluorescence07:55

Visualization of DNA Repair Proteins Interaction by Immunofluorescence

Published on: June 26, 2020

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...